Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,163 | 4,759 | 3,372 | 2,861 | 5,250 |
| Marketable Securities | 10,818 | 10,680 | 13,618 | 9,993 | 9,911 |
| TOTAL | $14,141 | $15,674 | $17,389 | $13,370 | $15,658 |
| Non-Current Assets | |||||
| Intangibles | 627 | 653 | 679 | 705 | 731 |
| Other Non-Current Assets | 300 | 383 | 383 | 383 | 50 |
| TOTAL | $927 | $1,036 | $1,062 | $1,088 | $781 |
| Total Assets | $15,068 | $16,709 | $18,451 | $14,458 | $16,438 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 840 | 1,433 | 931 | 1,206 | 881 |
| Accrued Expenses | 3,741 | 2,981 | 3,232 | 2,322 | 2,716 |
| TOTAL | $4,580 | $4,414 | $4,163 | $3,528 | $3,597 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,074 | 3,224 | 3,374 | 3,524 | 3,674 |
| TOTAL | $3,074 | $3,224 | $3,374 | $3,524 | $3,674 |
| Total Liabilities | $7,654 | $7,638 | $7,536 | $7,051 | $7,271 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28 | 28 | 28 | N/A | N/A |
| Retained earnings | -44,153 | -42,227 | -40,120 | -37,517 | -35,516 |
| Other shareholders' equity | 68 | 68 | 68 | 68 | 68 |
| TOTAL | $7,414 | $9,072 | $10,914 | $7,407 | $9,168 |
| Total Liabilities And Equity | $15,068 | $16,710 | $18,451 | $14,458 | $16,438 |